Today: 20 June 2026

Leokadia Głogulska

Leokadia Głogulska is a financial and technology journalist at TS2.tech, covering stocks, artificial intelligence, space technology and global market developments. She graduated from Wrocław University of Economics and Business and previously worked in financial analysis before moving into business journalism. Her reporting focuses on helping readers understand the market trends, companies and technologies shaping the global economy.

Veeva Shares Drop Despite Earnings Beat, Investors Eye AI Move

Veeva Shares Drop Despite Earnings Beat, Investors Eye AI Move

Veeva shares slid 2.3% to $178.69 and dropped further after hours despite beating Q1 estimates and raising 2027 guidance, as investors weighed AI spending and CRM migration risks; management highlighted rapid AI progress and Vault CRM growth, but warned customer transitions could cause disruption, with Salesforce winning commitments from some large clients.
4 June 2026
···
Partners Group Drops 17% After Cap on $8.6 Billion Fund Outflows

Partners Group Drops 17% After Cap on $8.6 Billion Fund Outflows

Partners Group shares plunged 16% to CHF 687.30 after capping withdrawals from its $8.6 billion Global Value SICAV fund, as redemption requests hit 9.8% of net asset value, nearly double the 5% quarterly limit; the move triggered sharp declines in peers EQT, CVC, and Bridgepoint, and marked the worst day on record for Partners Group shares, now down about 30% for the year.
3 June 2026
·
Snap Lags Nasdaq, Turnaround Pressure Rises

Snap Lags Nasdaq, Turnaround Pressure Rises

Snap Inc. shares slid 1.5% to $5.76 Tuesday—about 45% below last July’s high—even as the broader market rose, spotlighting investor doubts about Snap’s turnaround despite first-quarter revenue growth, narrowed losses, and major cost cuts; ad growth remains sluggish and the upcoming Specs update on June 16 is seen as a key test for future revenue momentum.
3 June 2026
··
Bluejay Diagnostics Stock Nearly Triples After U.S. Manufacturing Deal — Here’s the FDA Catch

Bluejay Diagnostics Stock Nearly Triples After U.S. Manufacturing Deal — Here’s the FDA Catch

Bluejay Diagnostics shares soared 171% to $5.88 after announcing a U.S. manufacturing partnership for its Symphony sepsis-testing platform, as investors bet on the company’s move from clinical development to commercialization; however, the stock remains risky with ongoing capital needs, pending FDA clearance, and reliance on successful clinical and manufacturing milestones.
2 June 2026
·
1 … 7 8 9 10 11 12

Stock Market Today

  • SpaceX's Record IPO Could Boost Stock Market, Says Evercore
    June 20, 2026, 11:45 AM EDT. SpaceX's debut on the Nasdaq (SPCX) raised $75 billion, valuing the company at $1.75 trillion, with shares jumping nearly 19% on the first day. Evercore ISI analysts compare this IPO to Netscape's 1995 launch, suggesting it could reignite enthusiasm around transformative technologies and fuel a new bull market. Unlike the dot-com bubble, current market conditions show no recession fears, moderate Treasury yields, and strong AI-driven earnings growth. IPO volumes remain subdued compared to 1999, reducing speculative risk. Additionally, $7.9 trillion in money market funds could flow into equities, providing support. Evercore keeps its S&P 500 year-end target at 7,750 with a bullish outlook at 9,000, expecting a tech-led rally to continue.

Latest articles

Netflix Earnings Put Stock in Focus After Holiday Dip

Netflix Earnings Put Stock in Focus After Holiday Dip

20 June 2026
Netflix shares ended the holiday-shortened week down 3.7% at $77.38, underperforming the broader market as investors weighed fading takeover speculation and looked ahead to the July 16 earnings report, where margins, pricing, and ad growth will be in focus.
Plug Power finishes week up as investors look at funding changes

Plug Power finishes week up as investors look at funding changes

20 June 2026
Plug Power jumped 7.55% to $2.85 Thursday, capping a volatile, holiday-shortened week as investors eye a June 30 deadline to close a $132.5 million asset sale critical to its liquidity plan, with recent SEC filings highlighting ongoing dilution risks and Wall Street split on the stock’s outlook.
Go toTop